Modus Advisors’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.67M Buy
9,864
+2,744
+39% +$817K 0.73% 53
2025
Q4
$2.35M Buy
7,120
+3,396
+91% +$1.15M 0.62% 53
2025
Q3
$1.29M Buy
3,724
+463
+14% +$140K 0.35% 68
2025
Q2
$1.02M Buy
3,261
+572
+21% +$219K 0.3% 68
2025
Q1
$1.41M Buy
2,689
+699
+35% +$357K 0.46% 61
2024
Q4
$1.01M Sell
1,990
-16
-0.8% -$9.09K 0.32% 66
2024
Q3
$1.17M Sell
2,006
-358
-15% -$202K 0.39% 63
2024
Q2
$1.2M Buy
2,364
+1,100
+87% +$539K 0.43% 61
2024
Q1
$625K Buy
1,264
+41
+3% +$20.8K 0.23% 72
2023
Q4
$644K Sell
1,223
-115
-9% -$61.3K 0.26% 63
2023
Q3
$675K Sell
1,338
-19
-1% -$9.35K 0.29% 62
2023
Q2
$652K Buy
1,357
+187
+16% +$91.4K 0.28% 63
2023
Q1
$553K Buy
1,170
+32
+3% +$15.4K 0.25% 64
2022
Q4
$603K Sell
1,138
-286
-20% -$151K 0.29% 63
2022
Q3
$719K Hold
1,424
0.38% 58
2022
Q2
$731K Buy
+1,424
New +$715K 0.37% 60
2021
Q3
Sell
-80
Closed -$32K 236
2021
Q2
$32K Buy
+80
New +$31.9K 0.01% 175
2020
Q3
Sell
-210
Closed -$62K 202
2020
Q2
$62K Buy
+210
New +$60.2K 0.04% 109

Other funds holding UNH

Modus Advisors's UNH Position: Q1 2026 in Review

Modus Advisors increased its UnitedHealth (UNH) stake by 39% in Q1 2026, buying an estimated $817K and bringing the position to 9,864 shares worth $2.67M. The position accounts for 0.73% of the portfolio, ranked #53.

Modus Advisors first reported a position in UNH in Q2 2020 and has held it in 18 quarters since. 3,024 funds tracked by Wall St. Rank hold UNH as of Q1 2026.

  • Modus Advisors held 9,864 shares of UnitedHealth worth $2.67M as of Q1 2026.
  • Modus Advisors bought 2,744 UnitedHealth shares in Q1 2026, an estimated $817K.
  • UnitedHealth made up 0.73% of Modus Advisors's portfolio in Q1 2026, its #53 holding.
  • Modus Advisors first reported a position in UnitedHealth in Q2 2020 and has held it in 18 quarters since.
  • 3,024 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.

Based on Modus Advisors's 13F filing for Q1 2026, filed 4 May 2026.